Coloplast A/S (0QBO) Stock Statistics & Valuation Metrics

Coloplast A/S has a market cap or net worth of kr123.30B. The enterprise value is kr144.07B.

Coloplast A/S has 210,200,000 shares outstanding. The number of shares has decreased by -2.65% in one year.

Coloplast A/S’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Coloplast A/S is 33.7. Coloplast A/S’s PEG ratio is ―.

In the last 12 months, Coloplast A/S had revenue of 27.87B and earned 3.64B in profits. Earnings per share was 16.13.

In the last 12 months, operating cash flow was 6.64B and capital expenditures -1.40B, giving a free cash flow of 5.24B billion.

Coloplast A/S pays an annual dividend of ―, resulting in a dividend yield of ―

Coloplast A/S upcoming earnings date is Feb 6, 2026, TBA (Confirmed).

Coloplast A/S as a current ratio of ―, with Debt / Equity ratio of 147.22%

In the past 12 months, Coloplast A/S has paid 2.52B in taxes.

Coloplast A/S EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Coloplast A/S has kr947.00M in cash and marketable securities with kr24.26B in debt, giving a net cash position of -kr21.69B billion.

Gross margin is 67.55%, with operating margin of ―, and net profit margin of ―.

The average price target for Coloplast A/S is kr603.00, which is 11.43% higher than the current price. The consensus rating is Moderate Sell